[
  {
    "date": "2023-12-30",
    "symbol": "BDSX",
    "period": "FY",
    "netincomeloss": -52146000,
    "documenttype": "10-K",
    "amendmentflag": "false",
    "documentannualreport": "true",
    "documentperiodenddate": "2023-12-31",
    "documentfiscalyearfocus": 2023,
    "documentfiscalperiodfocus": "FY",
    "entitycentralindexkey": 1439725,
    "currentfiscalyearenddate": "--12-31",
    "documenttransitionreport": "false",
    "entityfilenumber": "001-39659",
    "entityregistrantname": "Biodesix, Inc.",
    "entityincorporationstatecountrycode": "DE",
    "entitytaxidentificationnumber": "20-3986492",
    "entityaddressaddressline1": "919 West Dillon Rd",
    "entityaddresscityortown": "Louisville",
    "entityaddressstateorprovince": "CO",
    "entityaddresspostalzipcode": 80027,
    "cityareacode": 303,
    "localphonenumber": "417-0500",
    "security12btitle": "Common Stock, par value $0.001 per share",
    "icfrauditorattestationflag": "false",
    "documentfinstmterrorcorrectionflag": "false",
    "tradingsymbol": "BDSX",
    "securityexchangename": "NASDAQ",
    "entitywellknownseasonedissuer": "No",
    "entityvoluntaryfilers": "Yes",
    "entitycurrentreportingstatus": "Yes",
    "entityinteractivedatacurrent": "Yes",
    "entityfilercategory": "Non-accelerated Filer",
    "entitysmallbusiness": "true",
    "entityemerginggrowthcompany": "true",
    "entityextransitionperiod": "false",
    "entityshellcompany": "false",
    "auditorname": "KPMG LLP",
    "auditorlocation": "Denver, CO",
    "auditorfirmid": 185,
    "cashandcashequivalentsatcarryingvalue": 26284000,
    "accountsreceivablenetcurrent": 7679000,
    "otherassetscurrent": 5720000,
    "assetscurrent": 39683000,
    "propertyplantandequipmentnet": 27867000,
    "intangibleassetsnetexcludinggoodwill": 7911000,
    "operatingleaserightofuseasset": 1745000,
    "goodwill": 15031000,
    "otherassetsnoncurrent": 6859000,
    "assetsnoncurrent": 59413000,
    "assets": 99096000,
    "accountspayablecurrent": 2929000,
    "accruedliabilitiescurrent": 7710000,
    "contractwithcustomerliabilitycurrent": 324000,
    "operatingleaseliabilitycurrent": 252000,
    "businesscombinationcontingentconsiderationliabilitycurrent": 21857000,
    "notespayabletobankcurrent": 51000,
    "otherliabilitiescurrent": 293000,
    "liabilitiescurrent": 33416000,
    "longtermnotespayable": 35225000,
    "operatingleaseliabilitynoncurrent": 25163000,
    "otherliabilitiesnoncurrent": 712000,
    "liabilitiesnoncurrent": 61100000,
    "liabilities": 94516000,
    "commonstockvalue": 96000,
    "additionalpaidincapital": 424050000,
    "retainedearningsaccumulateddeficit": -419566000,
    "stockholdersequity": 4580000,
    "liabilitiesandstockholdersequity": 99096000,
    "allowancefordoubtfulaccountsreceivable": 65000,
    "preferredstockparorstatedvaluepershare": 0.001,
    "preferredstocksharesauthorized": 5000000,
    "commonstockparorstatedvaluepershare": 0.001,
    "commonstocksharesauthorized": 200000000,
    "commonstocksharesissued": 96235883,
    "commonstocksharesoutstanding": 96235883,
    "revenues": 49087000,
    "directcostsandexpenses": 13010000,
    "researchanddevelopmentexpense": 9988000,
    "sellinggeneralandadministrativeexpense": 67387000,
    "impairmentofintangibleassetsfinitelived": 44000,
    "operatingexpenses": 90429000,
    "operatingincomeloss": -41342000,
    "interestexpense": 9536000,
    "fairvalueadjustmentofwarrants": 1274000,
    "othernonoperatingincome": 6000,
    "othernonoperatingincomeexpense": -10804000,
    "earningspersharebasic": -0.64,
    "earningspersharediluted": -0.64,
    "weightedaveragenumberofsharesoutstandingbasic": 82113000,
    "weightedaveragenumberofdilutedsharesoutstanding": 82113000,
    "sharesoutstanding": 96236000,
    "stockissuedduringperiodsharesnewissues": 17352000,
    "stockissuedduringperiodvaluenewissues": 17000,
    "stockissuedduringperiodsharesemployeestockpurchaseplans": 437000,
    "stockissuedduringperiodvalueemployeestockpurchaseplan": 643000,
    "stockissuedduringperiodsharesstockoptionsexercised": 123000,
    "stockissuedduringperiodvaluestockoptionsexercised": 91000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiodamount": 1000,
    "adjustmentstofirstamendmentwarrants": 674000,
    "adjustmentstoadditionalpaidincapitalreclassificationofwarrant": 1335000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiod": 710000,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 5373000,
    "profitloss": -52146000,
    "depreciationandamortization": 3328000,
    "operatingleaserightofuseassetamortizationexpense": 2179000,
    "sharebasedcompensation": 5373000,
    "provisionfordoubtfulaccounts": 497000,
    "accruedinterestamortizationofdebtissuancecostsandother": 5111000,
    "inventorywritedown": 166000,
    "increasedecreaseinaccountsreceivable": 4718000,
    "increasedecreaseinothercurrentassets": -905000,
    "increasedecreaseinothernoncurrentassets": -33000,
    "increasedecreaseinaccountspayableandaccruedliabilities": 513000,
    "increasedecreaseincontractwithcustomerliability": -755000,
    "increasedecreaseincontingentconsideration": -2494000,
    "tenantimprovementallowancesreceived": 18323000,
    "increasedecreaseinoperatingleaseliability": -503000,
    "netcashprovidedbyusedinoperatingactivities": -22870000,
    "paymentstoacquirepropertyplantandequipment": 22919000,
    "paymentsforproceedsfrompatentcostsandintangibleassetacquisitionnet": 143000,
    "netcashprovidedbyusedininvestingactivities": -23062000,
    "proceedsfromissuanceofcommonstock": 28126000,
    "proceedsfromissuanceofcommonstockunderemployeestockpurchaseplan": 643000,
    "proceedsfromstockoptionsexercised": 91000,
    "paymentforcontingentconsiderationliabilityfinancingactivities": 8581000,
    "proceedsfromissuanceoftermloanandnotespayable": 10000000,
    "repaymentsoflongtermdebt": 49000,
    "paymentsofdebtissuancecosts": 833000,
    "paymentofequityfinancingcosts": 80000,
    "proceedsfrompaymentsforotherfinancingactivities": -188000,
    "netcashprovidedbyusedinfinancingactivities": 29129000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": -16803000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalents": 26371000,
    "debtissuancecostsincludedinaccountspayableandotheraccruedliabilities": 18000,
    "equityfinancingcostsincludedinaccountspayableandotheraccruedliabilities": 43000,
    "issuanceofperceptivewarrants": 674000,
    "rightofuseassetobtainedinexchangeforoperatingleaseliability": 797000,
    "rightofuseassetobtainedinexchangeforfinanceleaseliability": 773000,
    "interestpaidnet": 3994000,
    "reclassificationofwarrantliabilitytoadditionalpaidincapital": 1335000,
    "purchasesofpropertyequipmentincludedinaccountspayableandaccruedliabilities": 793000,
    "numberofcancertest": 5,
    "numberofcommercialbloodbasedtest": 2,
    "numberofsarscov2test": 3,
    "numberofoperatingsegments": 1,
    "restrictedcash": 100000,
    "restrictedcashcurrentassetstatementoffinancialpositionextensiblelist": "http://fasb.org/us-gaap/2023#OtherAssetsCurrent",
    "otherinventorysupplies": 1400000,
    "propertyplantandequipmentusefullife": "P3Y",
    "finitelivedintangibleassetusefullife": "P10Y",
    "lesseeoperatingleasedescription": "For lease classification determination, Management continues to use (i) 75% or greater to determine whether the lease term is a major part of the remaining economic life of the underlying asset and (ii) 90% or greater to determine whether the present value of the sum of lease payments is substantially all of the fair value of the underlying asset.",
    "debtinstrumentannualprincipalpayment": 40000000,
    "inventoryvaluationreserves": 100000,
    "customerfunds": 5000000,
    "operatingleaseliability": 25415000,
    "businessacquisitiondescriptionofacquiredentity": "requires additional consideration to be paid by the Company to such shareholders upon attainment of a three-consecutive month",
    "businessacquisitioncontingentconsiderationnumberofinstallments": 6,
    "longtermdebtfairvalue": 35276000,
    "liabilitiesfairvaluedisclosure": 21857000,
    "fairvaluemeasurementwithunobservableinputsreconciliationsrecurringbasisliabilityvalue": 21857000,
    "fairvaluemeasurementwithunobservableinputsreconciliationrecurringbasisliabilitygainlossincludedinearnings": 1274000,
    "fairvaluemeasurementwithunobservableinputsinterestexpense": 3946000,
    "fairvaluemeasurementwithunobservableinputspaymentsofcontingentconsideration": 11075000,
    "adjustmentstoadditionalpaidincapitalmarktomarket": -1335000,
    "percentageofprobabilitiesofcontingentconsiderationsuccessfulachievementmilestonediscountratesrange": 0.11,
    "interestexpenseduetopassageoftimeandfixedpaymentschedule": 3900000,
    "classofwarrantorrightnumberofsecuritiescalledbyeachwarrantorright": 613333,
    "propertyplantandequipmentgross": 6089000,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 5612000,
    "depreciation": 460000,
    "finitelivedintangibleassetsgross": 1975000,
    "finitelivedintangibleassetsaccumulatedamortization": 752000,
    "finitelivedintangibleassetsnet": 1223000,
    "indefinitelivedintangibleassetsexcludinggoodwillgross": 116000,
    "indefinitelivedintangibleassetsexcludinggoodwill": 116000,
    "intangibleassetsgrossexcludinggoodwill": 18991000,
    "intangibleassetsaccumulatedamortizationexcludinggoodwill": 11080000,
    "amortizationofintangibleassets": 2000,
    "finitelivedintangibleassetsamortizationexpensenexttwelvemonths": 1978000,
    "finitelivedintangibleassetsamortizationexpenseyeartwo": 1972000,
    "finitelivedintangibleassetsamortizationexpenseyearthree": 1959000,
    "finitelivedintangibleassetsamortizationexpenseyearfour": 1007000,
    "finitelivedintangibleassetsamortizationexpenseyearfive": 59000,
    "finitelivedintangibleassetsamortizationexpenseyearsixandthereafter": 820000,
    "employeerelatedliabilitiescurrent": 3855000,
    "accruedclinicaltrialexpensecurrent": 983000,
    "otheraccruedliabilitiescurrent": 2872000,
    "debtinstrumentcarryingamount": 40000000,
    "debtinstrumentunamortizeddiscountpremiumanddebtissuancecostsnet": 4802000,
    "notespayable": 35276000,
    "notespayablecurrent": 51000,
    "longtermdebt": 40078000,
    "debtinstrumentinterestrateeffectivepercentage": 0.144,
    "classofwarrantorrightexercisepriceofwarrantsorrights1": 0.75,
    "warrantsandrightsoutstandingmaturitydate": "2028-02-23",
    "longtermdebtmaturitiesrepaymentsofprincipalinnexttwelvemonths": 50000,
    "longtermdebtmaturitiesrepaymentsofprincipalinyeartwo": 21000,
    "longtermdebtmaturitiesrepaymentsofprincipalinyearthree": 7000,
    "longtermdebtmaturitiesrepaymentsofprincipalinyearfourandthereafter": 40000000,
    "areaofofficespaceleased": 9066,
    "leaseexpirationmonthyear": "2023-01",
    "lesseeoperatingleasetermofcontract": "P1Y",
    "operatingleaseexpense": 4300000,
    "operatingleaseweightedaverageremainingleaseterm1": "P10Y10M24D",
    "operatingleaseweightedaveragediscountratepercent": 0.114,
    "additionaltenantimprovementallowanceamount": 2000000,
    "tenantimprovements": 20800000,
    "tenantimprovementsincurredduringtheperiod": 18300000,
    "lesseeoperatingleaseliabilitypaymentsduenexttwelvemonths": 2406000,
    "lesseeoperatingleaseliabilitypaymentsdueyeartwo": 4032000,
    "lesseeoperatingleaseliabilitypaymentsdueyearthree": 4144000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfour": 4063000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfive": 4151000,
    "lesseeoperatingleaseliabilitytobepaidyearsixandthereafter": 28113000,
    "lesseeoperatingleaseliabilitypaymentsdue": 46909000,
    "lesseeoperatingleaseliabilityundiscountedexcessamount": 21494000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnonoptionequityinstrumentsgranted": 2474000,
    "classofwarrantorrightnumberofsecuritiescalledbywarrantsorrights": 103326,
    "commonstockvotingrights": "The holder of each share of common stock is entitled to one vote per share.",
    "numberoffacility": 2,
    "deferredofferingcosts": 654000,
    "proceedsfromissuanceofcommonstocknet": 600000,
    "weightedaveragepricepershare": 1.66,
    "lineofcreditfacilityremainingborrowingcapacity": 28900000,
    "contractwithcustomerliabilityrevenuerecognized": 1300000,
    "contractwithcustomerliabilitynoncurrent": 300000,
    "concentrationriskpercentage1": 0.1,
    "commonstockcapitalsharesreservedforfutureissuance": 1893395,
    "sharebasedcompensationarrangementbysharebasedpaymentawardpercentageofoutstandingstockmaximum": 0.04,
    "sharebasedcompensationarrangementbysharebasedpaymentawardmaximumemployeesubscriptionrate": 0.15,
    "sharebasedcompensationarrangementbysharebasedpaymentawarddiscountfrommarketpriceofferingdate": 0.85,
    "descriptionofvotingpowerorvalueofstockforemployeeparticipationinofferingperiod": "No employee may participate in an offering period if the employee owns 5% or more of the total combined voting power or value of the Company’s stock.",
    "descriptionofofferingperiodunderplan": "The ESPP provides for successive six-month offering periods beginning on September 1st and March 1st of each year. During the year ended December 31, 2023, 437,135 shares were issued under the ESPP leaving 309,012 shares remaining for future issuance.",
    "sharebasedcompensationarrangementbysharebasedpaymentawardexpirationperiod": "P10Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingrights": "Performance-based options vest in three equal annual installments beginning one year after the grant date",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 1050000,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 2,
    "allocatedsharebasedcompensationexpense": 400000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedsharebasedawardsotherthanoptions": 5900000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": "P2Y6M",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 876000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresandexpirationsinperiod": 217000,
    "stockissuedduringperiodsharesstockoptionscancelledundertheoptionexchange": 169000,
    "stockissuedduringperiodsharesstockoptionsgrantedundertheoptionexchange": 34000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": 1016000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 2.81,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresandexpirationsinperiodweightedaverageexerciseprice": 4.52,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice": 0.74,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptioncancelledundertheoptionexchangeweightedaverageexerciseprice": 20.67,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptiongrantedundertheoptionexchangeweightedaverageexerciseprice": 1.2,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 2.86,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": "P8Y4M24D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm1": "P8Y3M18D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 22000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableintrinsicvalue1": 748000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P5Y4M20D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 0.801,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.0398,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsnonvestednumberofshares": 2729000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsnonvestedoptionsforfeitednumberofshares": 246000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 1.92,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeituresweightedaveragegrantdatefairvalue": 2.52,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiodweightedaveragegrantdatefairvalue": 2.48,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestedweightedaveragegrantdatefairvalue": 1.91,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 3091000,
    "deferredtaxassetsoperatinglosscarryforwardssubjecttoexpiration": 310400000,
    "deferredtaxassetsresearchandexperimentationtaxcarryforwardssubjecttoexpiration": 5200000,
    "taxcreditcarryforwarddescription": "expire beginning in 2026",
    "valuationallowancedeferredtaxassetexplanationofchange": "Company does not believe it is more likely than not that it will realize the benefits of net deferred tax assets and, accordingly, has established a valuation allowance equal to 100% of net deferred tax assets.",
    "percentageofvaluationallowanceequaltonetdeferredtaxassets": 1,
    "valuationallowancedeferredtaxassetchangeinamount": 10500000,
    "incometaxexaminationdescription": "federal and state returns for all years will remain open to examination by federal and state tax authorities for three and four years, respectively, from the date of utilization of any net operating loss carryforwards.",
    "incometaxexaminationlikelihoodofunfavorablesettlement": "For tax positions meeting the more likely than not threshold, the amount recognized in the financial statements is the largest benefit that has a greater than 50% likelihood of being realized upon ultimate settlement with the relevant tax authority.",
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "effectiveincometaxratereconciliationstateandlocalincometaxes": 0.01,
    "effectiveincometaxratereconciliationtaxcreditsresearch": 0.01,
    "effectiveincometaxratereconciliationpermanentitems": 0.03,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": -0.2,
    "deferredtaxassetsoperatinglosscarryforwards": 72722000,
    "deferredtaxassetstaxcreditcarryforwardsresearch": 4149000,
    "deferredtaxassetinterestcarryforward": 5120000,
    "deferredtaxassetscapitalizedresearchcosts": 4281000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": 1685000,
    "deferredtaxassetsleaseliability": 6398000,
    "deferredtaxassetstaxdeferredexpensereservesandaccruals": 667000,
    "deferredtaxassetsgross": 95022000,
    "deferredtaxassetsvaluationallowance": 93023000,
    "deferredtaxassetsnet": 1999000,
    "deferredtaxliabilitiespropertyplantandequipment": 4000,
    "deferredtaxliabilitiesrightofuseasset": -692000,
    "deferredtaxliabilitiesgoodwillandintangibleassetsintangibleassets": 1303000,
    "deferredincometaxliabilities": 1999000,
    "unrecognizedtaxbenefits": 1037000,
    "unrecognizedtaxbenefitsincreasesresultingfromcurrentperiodtaxpositions": 57000,
    "unrecognizedtaxbenefitsincreasesresultingfrompriorperiodtaxpositions": 28000,
    "remainingestimatedobligation": 100000,
    "licenseagreementexpirydate": "2024-08",
    "royaltyexpense": 200000,
    "percentageofrevenuesharepaymentrelatedtonodifycdttestrecognizedrevenuefornonscreeningtests": 0.08,
    "minimumannualvolumepercentagethereafter": 0.05,
    "periodofescalationsofsales": "through the first four years of sales"
  },
  {
    "date": "2022-12-30",
    "symbol": "BDSX",
    "period": "FY",
    "documenttype": "10-K",
    "amendmentflag": "false",
    "documentannualreport": "true",
    "documentperiodenddate": "December 31, 2022",
    "documentfiscalyearfocus": 2022,
    "documentfiscalperiodfocus": "FY",
    "entitycentralindexkey": 1439725,
    "currentfiscalyearenddate": "--12-31",
    "documenttransitionreport": "false",
    "entityfilenumber": "001-39659",
    "entityregistrantname": "Biodesix, Inc.",
    "entityincorporationstatecountrycode": "Delaware",
    "entitytaxidentificationnumber": "20-3986492",
    "entityaddressaddressline1": "2970 Wilderness Place",
    "entityaddressaddressline2": "Suite 100",
    "entityaddresscityortown": "Boulder",
    "entityaddressstateorprovince": "CO",
    "entityaddresspostalzipcode": 80301,
    "cityareacode": 303,
    "localphonenumber": "417-0500",
    "security12btitle": "Common Stock, par value $0.001 per share",
    "icfrauditorattestationflag": "false",
    "tradingsymbol": "BDSX",
    "securityexchangename": "The NASDAQ Global Market",
    "entitywellknownseasonedissuer": "No",
    "entityvoluntaryfilers": "Yes",
    "entitycurrentreportingstatus": "Yes",
    "entityinteractivedatacurrent": "Yes",
    "entityfilercategory": "Non-accelerated filer",
    "entitysmallbusiness": "true",
    "entityemerginggrowthcompany": "true",
    "entityextransitionperiod": "false",
    "entityshellcompany": "false",
    "auditorname": "KPMG LLP",
    "auditorlocation": "Denver, CO",
    "auditorfirmid": 185,
    "cashandcashequivalentsatcarryingvalue": 43100000,
    "accountsreceivablenetcurrent": 5065000,
    "otherassetscurrent": 5181000,
    "assetscurrent": 53334000,
    "propertyplantandequipmentnet": 5848000,
    "intangibleassetsnetexcludinggoodwill": 9797000,
    "operatingleaserightofuseasset": 2000000,
    "goodwill": 15031000,
    "otherassetsnoncurrent": 5923000,
    "assetsnoncurrent": 39572000,
    "assets": 92906000,
    "accountspayablecurrent": 1685000,
    "accruedliabilitiescurrent": 8218000,
    "contractwithcustomerliabilitycurrent": 700000,
    "operatingleaseliabilitycurrent": 1543000,
    "businesscombinationcontingentconsiderationliabilitycurrent": 10341000,
    "notespayabletobankcurrent": 49000,
    "otherliabilitiescurrent": 41000,
    "liabilitiescurrent": 22839000,
    "longtermnotespayable": 25004000,
    "operatingleaseliabilitynoncurrent": 5254000,
    "businesscombinationcontingentconsiderationliabilitynoncurrent": 18645000,
    "otherliabilitiesnoncurrent": 558000,
    "liabilitiesnoncurrent": 49461000,
    "liabilities": 72300000,
    "commonstockvalue": 78000,
    "additionalpaidincapital": 387948000,
    "retainedearningsaccumulateddeficit": -367420000,
    "stockholdersequity": -367420000,
    "liabilitiesandstockholdersequity": 92906000,
    "allowancefordoubtfulaccountsreceivable": 118000,
    "preferredstockparorstatedvaluepershare": 0.001,
    "preferredstocksharesauthorized": "null",
    "commonstockparorstatedvaluepershare": 0.001,
    "commonstocksharesauthorized": "null",
    "commonstocksharesissued": "null",
    "commonstocksharesoutstanding": "null",
    "revenues": 3674000,
    "directcostsandexpenses": 14154000,
    "researchanddevelopmentexpense": 13102000,
    "sellinggeneralandadministrativeexpense": 61462000,
    "impairmentofintangibleassetsfinitelived": 81000,
    "operatingexpenses": 88799000,
    "operatingincomeloss": -50587000,
    "interestexpense": 8072000,
    "gainslossesonextinguishmentofdebt": -2934000,
    "fairvalueadjustmentofwarrants": 100000,
    "othernonoperatingincome": 109000,
    "othernonoperatingincomeexpense": -14860000,
    "netincomeloss": -65447000,
    "earningspersharebasic": -1.55,
    "earningspersharediluted": -1.55,
    "weightedaveragenumberofsharesoutstandingbasic": 42103000,
    "weightedaveragenumberofdilutedsharesoutstanding": 42103000,
    "sharesoutstanding": 77614000,
    "stockissuedduringperiodsharesnewissues": "null",
    "stockissuedduringperiodvaluenewissues": 56235000,
    "stockissuedduringperiodsharesemployeestockpurchaseplans": 194000,
    "stockissuedduringperiodvalueemployeestockpurchaseplan": 355000,
    "stockissuedduringperiodsharesfordeferredofferingcosts": 184000,
    "stockissuedduringperiodvaluesfordeferredofferingcosts": 600000,
    "stockissuedduringperiodsharesstockoptionsexercised": 384000,
    "stockissuedduringperiodvaluestockoptionsexercised": 269000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiod": 357000,
    "adjustmentstoadditionalpaidincapitalwarrantissued": 2906000,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 5961000,
    "profitloss": -65447000,
    "depreciationandamortization": 3597000,
    "operatingleaserightofuseassetamortizationexpense": 2247000,
    "sharebasedcompensation": 5961000,
    "provisionfordoubtfulaccounts": 93000,
    "accruedinterestamortizationofdebtissuancecostsandother": 5037000,
    "inventorywritedown": 906000,
    "increasedecreaseinaccountsreceivable": 1501000,
    "increasedecreaseinothercurrentassets": -1113000,
    "increasedecreaseinothernoncurrentassetsandliabilitiesnet": 3504000,
    "increasedecreaseinaccountspayableandaccruedliabilities": -773000,
    "increasedecreaseincontractwithcustomerliability": -1213000,
    "tenantimprovementallowancesreceived": 2471000,
    "increasedecreaseinoperatingleaseliability": -937000,
    "netcashprovidedbyusedinoperatingactivities": -44972000,
    "paymentstoacquirepropertyplantandequipment": 3298000,
    "paymentsforproceedsfrompatentcostsandintangibleassetacquisitionnet": 236000,
    "netcashprovidedbyusedininvestingactivities": -3534000,
    "proceedsfromissuanceofcommonstock": 7300000,
    "proceedsfromissuanceofcommonstockunderemployeestockpurchaseplan": 355000,
    "proceedsfromstockoptionsexercised": 269000,
    "paymentforcontingentconsiderationliabilityfinancingactivities": 10822000,
    "proceedsfromissuanceoftermloanandnotespayable": 45102000,
    "repaymentsoflongtermdebt": 28604000,
    "paymentsofdebtissuancecosts": 3725000,
    "paymentofdeferredofferingcosts": 129000,
    "paymentsofstockissuancecosts": 3069000,
    "proceedsfrompaymentsforotherfinancingactivities": -33000,
    "netcashprovidedbyusedinfinancingactivities": 58882000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": 10376000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalents": 43174000,
    "commonstockissuedfordeferredofferingcosts": 600000,
    "deferredofferingcostsamortizedagainstadditionalpaidincapital": 75000,
    "issuanceofperceptivewarrants": 3051000,
    "debtissuancecostsincludedinaccountspayableandotheraccruedliabilities": 631000,
    "equityfinancingcostsincludedinaccountspayableandotheraccruedliabilities": 160000,
    "operatingleaserightofuseassetsobtainedinexchangeforleaseliabilitiesatadoptionofasc842": 1269000,
    "rightofuseassetobtainedinexchangeforoperatingleaseliability": 3936000,
    "rightofuseassetobtainedinexchangeforfinanceleaseliability": 123000,
    "interestpaidnet": 1009000,
    "numberofcancertest": 5,
    "numberofcommercialbloodbasedtest": 2,
    "numberofsarscov2test": 3,
    "numberofoperatingsegments": 1,
    "restrictedcash": 100000,
    "restrictedcashcurrentassetstatementoffinancialpositionextensiblelist": "http://fasb.org/us-gaap/2022#OtherAssetsNoncurrent",
    "otherinventorysupplies": 1400000,
    "propertyplantandequipmentusefullife": "five years",
    "finitelivedintangibleassetusefullife": "10 years",
    "debtinstrumentannualprincipalpayment": 30000000,
    "inventoryvaluationreserves": 100000,
    "classofwarrantorrightnumberofsecuritiescalledbyeachwarrantorright": 613333,
    "classofwarrantorrightadditionalwarrantsorrightsexercisable": "null",
    "customerfunds": 5000000,
    "operatingleaseliability": 6797000,
    "lesseeoperatingleasedescription": "For lease classification determination, Management continues to use (i) 75% or greater to determine whether the lease term is a major part of the remaining economic life of the underlying asset and (ii) 90% or greater to determine whether the present value of the sum of lease payments is substantially all of the fair value of the underlying asset. ",
    "businessacquisitiondescriptionofacquiredentity": "If Indi elected to not exercise its option, the Company had 12 months to repurchase the common stock in two equal and consecutive quarterly cash installments totaling $37.0 million.",
    "businessacquisitioncontingentconsiderationnumberofinstallments": 6,
    "businesscombinationcontingentconsiderationarrangementscommonsharesredemptionamount": 4600000,
    "longtermdebtfairvalue": 26785000,
    "liabilitiesfairvaluedisclosure": 28986000,
    "warrantliabilitiesfairvaluedisclosure": 61000,
    "fairvaluemeasurementwithunobservableinputsreconciliationsrecurringbasisliabilityvalue": 61000,
    "fairvaluemeasurementwithunobservableinputsreconciliationrecurringbasisliabilitypurchases": 145000,
    "fairvaluemeasurementwithunobservableinputsreconciliationrecurringbasisliabilitygainlossincludedinearnings": -84000,
    "fairvaluemeasurementwithunobservableinputsinterestexpense": 3082000,
    "fairvaluemeasurementwithunobservableinputspaymentsofcontingentconsideration": -10822000,
    "repaymentsofdebt": 5700000,
    "businesscombinationcontingentconsiderationfinalpayment": 37000000,
    "percentageofprobabilitiesofcontingentconsiderationsuccessfulachievementmilestonediscountratesrange": 0.16,
    "interestexpenseduetopassageoftimeandfixedpaymentschedule": 3100000,
    "classofwarrantorrightexercisepriceofwarrantsorrights1": 4.46,
    "warrantsandrightsoutstandingmeasurementinput": 82,
    "fairvaluemeasurementwithunobservableinputsreconciliationrecurringbasisliabilityissues": 100000,
    "warrantsandrightsoutstandingmaturitydate": "February 23, 2028",
    "classofwarrantorrightnumberofsecuritiescalledbywarrantsorrights": 103326,
    "propertyplantandequipmentgross": 12866000,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 7018000,
    "depreciation": 1622000,
    "finitelivedintangibleassetsgross": 16900000,
    "finitelivedintangibleassetsaccumulatedamortization": 8450000,
    "finitelivedintangibleassetsnet": 9683000,
    "indefinitelivedintangibleassetsexcludinggoodwillgross": 114000,
    "indefinitelivedintangibleassetsexcludinggoodwill": 114000,
    "intangibleassetsgrossexcludinggoodwill": 18894000,
    "intangibleassetsaccumulatedamortizationexcludinggoodwill": 9097000,
    "amortizationofintangibleassets": 1975000,
    "finitelivedintangibleassetsamortizationexpensenexttwelvemonths": 1972000,
    "finitelivedintangibleassetsamortizationexpenseyeartwo": 1963000,
    "finitelivedintangibleassetsamortizationexpenseyearthree": 1957000,
    "finitelivedintangibleassetsamortizationexpenseyearfour": 1943000,
    "finitelivedintangibleassetsamortizationexpenseyearfive": 992000,
    "finitelivedintangibleassetsamortizationexpenseyearsixandthereafter": 856000,
    "employeerelatedliabilitiescurrent": 4671000,
    "accruedclinicaltrialexpensecurrent": 1232000,
    "otheraccruedliabilitiescurrent": 2315000,
    "debtinstrumentcarryingamount": 3000000,
    "debtinstrumentunamortizeddiscountpremiumanddebtissuancecostsnet": 5074000,
    "notespayable": 25053000,
    "notespayablecurrent": 49000,
    "debtinstrumentinterestrateeffectivepercentage": 0.133,
    "descriptionofsecuritiespurchaseagreement": "(i) purchased a secured promissory note (Promissory Note One) in the aggregate principal amount totaling $16.0 million in exchange for $15.0 million less certain expenses and (ii) agreed to purchase another secured promissory note at the Company’s election (Promissory Note Two and, together with Promissory Note One, the Promissory Notes), subject to certain conditions precedent in aggregate principal amount totaling $10.3 million in exchange for $10.0 million in cash proceeds.",
    "accruedinterestamortizationoforiginalissuediscountanddebtissuancecosts": 1800000,
    "longtermdebtmaturitiesrepaymentsofprincipalinnexttwelvemonths": 49000,
    "longtermdebtmaturitiesrepaymentsofprincipalinyeartwo": 50000,
    "longtermdebtmaturitiesrepaymentsofprincipalinyearthree": 21000,
    "longtermdebtmaturitiesrepaymentsofprincipalinyearfour": 7000,
    "longtermdebtmaturitiesrepaymentsofprincipalinyearfive": 30000000,
    "longtermdebt": 30127000,
    "areaofofficespaceleased": 29722,
    "additionaltenantimprovementallowanceamount": 2000000,
    "tenantimprovements": 2500000,
    "remainingcapacityunderthetenantimprovementallowances": 18300000,
    "lesseeoperatingleasetermofcontract": "P1Y",
    "operatingleaseexpense": 2600000,
    "operatingleaseweightedaverageremainingleaseterm1": 9,
    "operatingleaseweightedaveragediscountratepercent": 0.114,
    "leaseexpirationmonthyear": "2024-01",
    "lesseeoperatingleaseliabilitypaymentsduenexttwelvemonths": 2289000,
    "lesseeoperatingleaseliabilitypaymentsdueyeartwo": 2619000,
    "lesseeoperatingleaseliabilitypaymentsdueyearthree": 3710000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfour": 3978000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfive": 4063000,
    "lesseeoperatingleaseliabilitytobepaidyearsixandthereafter": 32263000,
    "lesseeoperatingleaseliabilitypaymentsdue": 48922000,
    "lesseeoperatingleaseliabilityundiscountedexcessamount": 23802000,
    "lesseeoperatingleaseliabilityamountrepresentingtenantimprovementallowances": 18323000,
    "tenantimprovementallowancesexpectedtobereceived": 18300000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnonoptionequityinstrumentsgranted": 1473000,
    "commonstockvotingrights": "The holder of each share of common stock is entitled to one vote per share.",
    "numberoffacility": 2,
    "adjustmentstoadditionalpaidincapitaldeferredofferingcosts": 75000,
    "deferredofferingcosts": 654000,
    "proceedsfromissuanceofcommonstocknet": 6800000,
    "weightedaveragepricepershare": 1.87,
    "lineofcreditfacilityremainingborrowingcapacity": 46900000,
    "primarysourcesofrevenuedescription": "We derive our revenue from two primary sources: (i) providing diagnostic testing in the clinical setting (Diagnostic tests); and (ii) providing biopharmaceutical companies with services that include diagnostic research, clinical research, clinical trial testing, development and testing services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics (Services).",
    "contractwithcustomerliabilitynoncurrent": 400000,
    "concentrationriskpercentage1": 0.18,
    "commonstockcapitalsharesreservedforfutureissuance": 100145,
    "sharebasedcompensationarrangementbysharebasedpaymentawardpercentageofoutstandingstockmaximum": 0.01,
    "sharebasedcompensationarrangementbysharebasedpaymentawardmaximumemployeesubscriptionrate": 0.15,
    "sharebasedcompensationarrangementbysharebasedpaymentawarddiscountfrommarketpriceofferingdate": 0.85,
    "descriptionofvotingpowerorvalueofstockforemployeeparticipationinofferingperiod": "No employee may participate in an offering period if the employee owns 5% or more of the total combined voting power or value of the Company’s stock.",
    "descriptionofofferingperiodunderplan": "The initial offering period was from January 1, 2021 through August 31, 2021. On a go-forward basis, the ESPP provides for successive six-month offering periods beginning on September 1st and March 1st of each year. As of December 31, 2022, 237,961 shares have been issued under the ESPP leaving 100,145 shares remaining for future issuance.",
    "sharebasedcompensationarrangementbysharebasedpaymentawardsharesissuedinperiod": 237961,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesavailableforgrant": 233519,
    "sharebasedcompensationarrangementbysharebasedpaymentawardexpirationperiod": "ten-year",
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingrights": "Performance-based options vest in three equal annual installments beginning one year after the grant date",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 2541000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 380000,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 2.92,
    "allocatedsharebasedcompensationexpense": 5961000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognized": 7100000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": 2.8,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestedweightedaveragegrantdatefairvalue": 2.36,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresandexpirationsinperiod": 333000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": 1525000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 8.4,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresandexpirationsinperiodweightedaverageexerciseprice": 8.23,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice": 0.7,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 7.28,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": 7.4,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm1": 6.8,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 1489000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableintrinsicvalue1": 1067000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": 5.65,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 0.726,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.013200000000000002,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsnonvestednumberofshares": 1211000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsnonvestedoptionsforfeitednumberofshares": 56000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 2.75,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeituresweightedaveragegrantdatefairvalue": 3.69,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiodweightedaveragegrantdatefairvalue": 5.01,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 9461000,
    "deferredtaxassetsoperatinglosscarryforwardssubjecttoexpiration": 299900000,
    "deferredtaxassetsresearchandexperimentationtaxcarryforwardssubjecttoexpiration": 4800000,
    "taxcreditcarryforwarddescription": "expire beginning in 2026",
    "valuationallowancedeferredtaxassetexplanationofchange": "Company does not believe it is more likely than not that it will realize the benefits of net deferred tax assets and, accordingly, has established a valuation allowance equal to 100% of net deferred tax assets.",
    "percentageofvaluationallowanceequaltonetdeferredtaxassets": 1,
    "valuationallowancedeferredtaxassetchangeinamount": 15100000,
    "incometaxexaminationdescription": "federal and state returns for all years will remain open to examination by federal and state tax authorities for three and four years, respectively, from the date of utilization of any net operating loss carryforwards.",
    "incometaxexaminationlikelihoodofunfavorablesettlement": "For tax positions meeting the more likely than not threshold, the amount recognized in the financial statements is the largest benefit that has a greater than 50 percent likelihood of being realized upon ultimate settlement with the relevant tax authority.",
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "effectiveincometaxratereconciliationstateandlocalincometaxes": 0.05,
    "effectiveincometaxratereconciliationtaxcreditsresearch": 0.01,
    "effectiveincometaxratereconciliationpermanentitems": 0.04,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": -0.23,
    "deferredtaxassetsoperatinglosscarryforwards": 70822000,
    "deferredtaxassetstaxcreditcarryforwardsresearch": 3807000,
    "deferredtaxassetinterestcarryforward": 3036000,
    "deferredtaxassetspropertyplantandequipment": 234000,
    "deferredtaxassetscapitalizedresearchcosts": 2874000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": 1619000,
    "deferredtaxassetstaxdeferredexpensereservesandaccruals": 1932000,
    "deferredtaxassetsgross": 84324000,
    "deferredtaxassetsvaluationallowance": 82552000,
    "deferredtaxassetsnet": 1772000,
    "deferredtaxliabilitiesgoodwillandintangibleassetsintangibleassets": 1772000,
    "deferredincometaxliabilities": 1772000,
    "unrecognizedtaxbenefits": 952000,
    "unrecognizedtaxbenefitsincreasesresultingfromcurrentperiodtaxpositions": 109000,
    "remainingestimatedobligation": 100000,
    "royaltyexpense": 900000,
    "percentageofrevenuesharepaymentrelatedtoacquireddiagnostictestrecognizedrevenuefornonscreeningtests": 0.08,
    "minimumannualvolumepercentagethereafter": 0.05,
    "periodofescalationsofsales": " through the first four years of sales"
  },
  {
    "date": "2021-12-30",
    "symbol": "BDSX",
    "period": "FY",
    "documenttype": "10-K",
    "amendmentflag": "false",
    "documentannualreport": "true",
    "documentperiodenddate": "December 31, 2021",
    "documentfiscalyearfocus": 2021,
    "documentfiscalperiodfocus": "FY",
    "entitycentralindexkey": 1439725,
    "currentfiscalyearenddate": "--12-31",
    "documenttransitionreport": "false",
    "entityfilenumber": "001-39659",
    "entityregistrantname": "Biodesix, Inc.",
    "entityincorporationstatecountrycode": "Delaware",
    "entitytaxidentificationnumber": "20-3986492",
    "entityaddressaddressline1": "2970 Wilderness Place",
    "entityaddressaddressline2": "Suite 100",
    "entityaddresscityortown": "Boulder",
    "entityaddressstateorprovince": "CO",
    "entityaddresspostalzipcode": 80301,
    "cityareacode": 303,
    "localphonenumber": "417-0500",
    "security12btitle": "Common Stock, par value $0.001 per share",
    "icfrauditorattestationflag": "false",
    "tradingsymbol": "BDSX",
    "securityexchangename": "The NASDAQ Global Market",
    "entitywellknownseasonedissuer": "No",
    "entityvoluntaryfilers": "Yes",
    "entitycurrentreportingstatus": "Yes",
    "entityinteractivedatacurrent": "Yes",
    "entityfilercategory": "Non-accelerated filer",
    "entitysmallbusiness": "true",
    "entityemerginggrowthcompany": "true",
    "entityextransitionperiod": "false",
    "entityshellcompany": "false",
    "auditorname": "KPMG LLP",
    "auditorlocation": "Denver, CO",
    "auditorfirmid": 185,
    "cashandcashequivalentsatcarryingvalue": 40000,
    "accountsreceivablenetcurrent": 3656000,
    "otherassetscurrent": 7245000,
    "assetscurrent": 43613000,
    "propertyplantandequipmentnet": 4179000,
    "intangibleassetsnetexcludinggoodwill": 11617000,
    "goodwill": 15031000,
    "otherassetsnoncurrent": 1657000,
    "assetsnoncurrent": 32484000,
    "assets": 76097000,
    "accountspayablecurrent": 1662000,
    "accruedliabilitiescurrent": 7665000,
    "contractwithcustomerliabilitycurrent": 1400000,
    "businesscombinationcontingentconsiderationliabilitycurrent": 17764000,
    "notespayabletobankcurrent": 19000,
    "liabilitiescurrent": 28960000,
    "longtermnotespayable": 9993000,
    "businesscombinationcontingentconsiderationliabilitynoncurrent": 16028000,
    "otherliabilitiesnoncurrent": 1389000,
    "liabilitiesnoncurrent": 27410000,
    "liabilities": 56370000,
    "commonstockvalue": 31000,
    "additionalpaidincapital": 321669000,
    "retainedearningsaccumulateddeficit": -301973000,
    "stockholdersequity": -301973000,
    "liabilitiesandstockholdersequity": 76097000,
    "allowancefordoubtfulaccountsreceivable": 158000,
    "preferredstockparorstatedvaluepershare": 0.001,
    "preferredstocksharesauthorized": "null",
    "commonstockparorstatedvaluepershare": 0.001,
    "commonstocksharesauthorized": "null",
    "commonstocksharesissued": "null",
    "commonstocksharesoutstanding": "null",
    "revenues": 5569000,
    "directcostsandexpenses": 30518000,
    "researchanddevelopmentexpense": 12789000,
    "sellinggeneralandadministrativeexpense": 50517000,
    "changeinfairvalueofcontingentconsiderationexcludingaccretionexpense": 1622000,
    "operatingexpenses": 95446000,
    "operatingincomeloss": -40940000,
    "interestexpense": 4508000,
    "gainslossesonextinguishmentofdebt": 2298000,
    "othernonoperatingincome": 9000,
    "othernonoperatingincomeexpense": -2219000,
    "netincomeloss": -43159000,
    "earningspersharebasicanddiluted": -1.58,
    "weightedaveragenumberofshareoutstandingbasicanddiluted": "null",
    "sharesoutstanding": 30790000,
    "stockissuedduringperiodvaluenewissues": 15679000,
    "stockissuedduringperiodsharesnewissues": "null",
    "stockissuedduringperiodvalueemployeestockpurchaseplan": 328000,
    "stockissuedduringperiodsharesemployeestockpurchaseplans": 43000,
    "stockissuedduringperiodvaluestockoptionsexercised": 769000,
    "stockissuedduringperiodsharesstockoptionsexercised": 408,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 4944000,
    "capitalunitsdeductionsfromtotalcosttoinvestors": 664000,
    "profitloss": -43159000,
    "depreciationandamortization": 3178000,
    "sharebasedcompensation": 4944000,
    "businesscombinationcontingentconsiderationarrangementschangeinamountofcontingentconsiderationliability1": 2200,
    "provisionfordoubtfulaccounts": 193000,
    "accruedinterestamortizationofdebtissuancecostsandother": 2706000,
    "increasedecreaseinaccountsreceivable": -11454000,
    "increasedecreaseinothercurrentassets": -1369000,
    "increasedecreaseinothernoncurrentassetsandliabilitiesnet": -875000,
    "increasedecreaseinaccountspayableandaccruedliabilities": -7425000,
    "increasedecreaseincontractwithcustomerliability": -1682000,
    "netcashprovidedbyusedinoperatingactivities": -28223000,
    "paymentstoacquirepropertyplantandequipment": 2241000,
    "paymentsforproceedsfrompatentcostsandintangibleassetacquisitionnet": 306000,
    "netcashprovidedbyusedininvestingactivities": -2547000,
    "proceedsfromissuanceofcommonstock": 16300000,
    "proceedsfromissuanceofcommonstockunderemployeestockpurchaseplan": 328000,
    "proceedsfromstockoptionsexercised": 769000,
    "proceedsfromissuanceoftermloanandnotespayable": 30078000,
    "repaymentsoflongtermdebt": 45428000,
    "paymentsofdebtissuancecosts": 164000,
    "paymentsofstockissuancecosts": 664000,
    "netcashprovidedbyusedinfinancingactivities": 1262000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": -29508000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalents": 32798000,
    "interestpaidnet": 1676000,
    "debtissuancecostsincurredduringnoncashorpartialnoncashtransaction": 15000,
    "numberofcancertest": 5,
    "numberofcommercialbloodbasedtest": 2,
    "numberofsarscov2test": 3,
    "sharesissuedpricepershare": 4.35,
    "classofwarrantorrightnumberofsecuritiescalledbywarrantsorrights": 103326,
    "proceedsfromissuanceorsaleofequity": 16300000,
    "debtinstrumentcarryingamount": 75000,
    "numberofoperatingsegments": 1,
    "restrictedcash": 100000,
    "otherinventorysupplies": 2900000,
    "propertyplantandequipmentusefullife": "five years",
    "finitelivedintangibleassetusefullife": 10,
    "cashacquiredfromacquisition": 2000000,
    "percentageofprobabilitiesofcontingentconsiderationsuccessfulachievementmilestonediscountratesrange": 0.135,
    "debtinstrumentannualprincipalpayment": 10000000,
    "operatingleaserightofuseasset": 1500000,
    "operatingleaserightofuseassetstatementoffinancialpositionextensiblelist": "http://fasb.org/us-gaap/2021-01-31#OtherAssetsNoncurrent",
    "operatingleaseliability": 1500000,
    "operatingleaseliabilitystatementoffinancialpositionextensiblelist": "http://fasb.org/us-gaap/2021-01-31#OperatingLeaseLiability",
    "businessacquisitiondescriptionofacquiredentity": "If Indi elected to not exercise its option, the Company had 12 months to repurchase the common stock in two equal and consecutive quarterly cash installments totaling $37.0 million.",
    "businessacquisitioncontingentconsiderationnumberofinstallments": 6,
    "businesscombinationcontingentconsiderationarrangementscommonsharesredemptionamount": 4600000,
    "longtermdebtfairvalue": 10012000,
    "liabilitiesfairvaluedisclosure": 33792000,
    "fairvaluemeasurementwithunobservableinputsreconciliationsrecurringbasisliabilityvalue": 33792000,
    "fairvaluemeasurementwithunobservableinputsreconciliationrecurringbasisliabilitygainlossincludedinearnings": 1622000,
    "fairvaluemeasurementwithunobservableinputsinterestexpense": 2238000,
    "repaymentsofdebt": 9300000,
    "businesscombinationcontingentconsiderationfinalpayment": 37000000,
    "classofwarrantorrightnumberofsecuritiescalledbyeachwarrantorright": 613333,
    "classofwarrantorrightexercisepriceofwarrantsorrights1": 4.46,
    "warrantsandrightsoutstandingmaturitydate": "February 23, 2028",
    "warrantsnotsettleableincashfairvaluedisclosure": 300000,
    "propertyplantandequipmentgross": 10928000,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 6749000,
    "depreciation": 1228000,
    "finitelivedintangibleassetsgross": 16900000,
    "finitelivedintangibleassetsaccumulatedamortization": 6572000,
    "finitelivedintangibleassetsnet": 11517000,
    "indefinitelivedintangibleassetsexcludinggoodwillgross": 100000,
    "indefinitelivedintangibleassetsexcludinggoodwill": 100000,
    "intangibleassetsgrossexcludinggoodwill": 18755000,
    "intangibleassetsaccumulatedamortizationexcludinggoodwill": 7138000,
    "amortizationofintangibleassets": 1950000,
    "finitelivedintangibleassetsamortizationexpensenexttwelvemonths": 1975000,
    "finitelivedintangibleassetsamortizationexpenseyeartwo": 1969000,
    "finitelivedintangibleassetsamortizationexpenseyearthree": 1959000,
    "finitelivedintangibleassetsamortizationexpenseyearfour": 1954000,
    "finitelivedintangibleassetsamortizationexpenseyearfive": 1941000,
    "finitelivedintangibleassetsamortizationexpenseyearsixandthereafter": 1719000,
    "employeerelatedliabilitiescurrent": 4029000,
    "accruedclinicaltrialexpensecurrent": 870000,
    "otheraccruedliabilitiescurrent": 2766000,
    "debtinstrumentunamortizeddiscountpremiumanddebtissuancecostsnet": 63000,
    "notespayable": 10012000,
    "notespayablecurrent": 19000,
    "percentageofminimumrevenuerequirement": 0.75,
    "debtinstrumentcovenantdescription": "The 2021 Term Loan requires the Company to comply with a minimum liquidity ratio covenant (as defined) by the 2021 Term Loan of not less than 0.95 to 1.00, and has a trailing six month rolling minimum revenue requirement of not less than 70% of the Company’s projected revenue performed at the end of each reporting period.",
    "debtinstrumentcovenantcompliance": "the Company was in compliance with all restrictive and financial covenants associated with its borrowings.",
    "cashcollateralforborrowedsecurities": 15000000,
    "debtinstrumentdescription": "The PPP Loan had a maturity date on the two-year anniversary of the funding date, April 2022, and included a fixed rate of 1.00% per annum. Monthly principal and interest payments, less the amount of any potential forgiveness (as discussed below), were scheduled to commence in September 2021. The Company did not provide any collateral or guarantees in connection with the PPP Loan, nor did the ",
    "longtermdebtmaturitiesrepaymentsofprincipalinnexttwelvemonths": 19000,
    "longtermdebtmaturitiesrepaymentsofprincipalinyeartwo": 15000,
    "longtermdebtmaturitiesrepaymentsofprincipalinyearthree": 4017000,
    "longtermdebtmaturitiesrepaymentsofprincipalinyearfour": 4818000,
    "longtermdebtmaturitiesrepaymentsofprincipalinyearfive": 1206000,
    "longtermdebt": 10075000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnonoptionequityinstrumentsoutstandingnumber": 150811,
    "commonstockvotingrights": "The holder of each share of common stock is entitled to one vote per share.",
    "saleofstockpricepershare": 4.35,
    "proceedsfromissuanceofcommonstocknet": 15700000,
    "underwritingdiscountsandcommissionsandofferingexpensespayable": 700000,
    "primarysourcesofrevenuedescription": "We derive our revenue from two primary sources: (i) providing diagnostic testing in the clinical setting (Diagnostic Tests); and (ii) providing biopharmaceutical companies with services that include diagnostic research, clinical research, clinical trial testing, development and testing services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics (Services).",
    "contractwithcustomerliabilitynoncurrent": 800,
    "concentrationriskpercentage1": 0.11,
    "commonstockcapitalsharesreservedforfutureissuance": 295251,
    "sharebasedcompensationarrangementbysharebasedpaymentawardpercentageofoutstandingstockmaximum": 0.01,
    "sharebasedcompensationarrangementbysharebasedpaymentawardmaximumemployeesubscriptionrate": 0.15,
    "sharebasedcompensationarrangementbysharebasedpaymentawarddiscountfrommarketpriceofferingdate": 0.85,
    "descriptionofvotingpowerorvalueofstockforemployeeparticipationinofferingperiod": "No employee may participate in an offering period if the employee owns 5% or more of the total combined voting power or value of the Company’s stock.",
    "descriptionofofferingperiodunderplan": "The initial offering period was from January 1, 2021 through August 31, 2021. On a go-forward basis, the ESPP provides for successive six-month offering periods beginning on September 1st and March 1st of each year. As of December 31, 2021, 42,855 shares have been issued under the ESPP leaving 295,251 shares remaining for future issuance.",
    "sharebasedcompensationarrangementbysharebasedpaymentawardsharesissuedinperiod": 42855,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesavailableforgrant": 630685,
    "sharebasedcompensationarrangementbysharebasedpaymentawardexpirationperiod": "ten-year",
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingrights": "Performance-based options vest in three equal annual installments beginning one year after the grant date",
    "numberofequalannualinstallmentsforawardvesting": 3,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 1190,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 17.87,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestednumberofshares": 56156,
    "allocatedsharebasedcompensationexpense": 4944000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognized": 7800000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": 3.8,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiod": 71707,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestedweightedaveragegrantdatefairvalue": 5.3,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 2878000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresandexpirationsinperiod": 225,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": 1428,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 8.08,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresandexpirationsinperiodweightedaverageexerciseprice": 7.22,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice": 1.51,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 5.02,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": 7.7,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm1": 6.7,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 6288000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableintrinsicvalue1": 3849000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": 6.01,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 0.685,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.0079,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 3535000,
    "deferredtaxassetsoperatinglosscarryforwardssubjecttoexpiration": 267100000.00000003,
    "deferredtaxassetsresearchandexperimentationtaxcarryforwardssubjecttoexpiration": 4200000,
    "taxcreditcarryforwarddescription": "expire beginning in 2026",
    "valuationallowancedeferredtaxassetexplanationofchange": "Company does not believe it is more likely than not that it will realize the benefits of net deferred tax assets and, accordingly, has established a valuation allowance equal to 100% of net deferred tax assets.",
    "percentageofvaluationallowanceequaltonetdeferredtaxassets": 1,
    "valuationallowancedeferredtaxassetchangeinamount": 11400000,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "effectiveincometaxratereconciliationstateandlocalincometaxes": 0.05,
    "effectiveincometaxratereconciliationtaxcreditsresearch": 0.01,
    "effectiveincometaxratereconciliationpermanentitems": 0.01,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": -0.26,
    "deferredtaxassetsoperatinglosscarryforwards": 61874000,
    "deferredtaxassetstaxcreditcarryforwardsresearch": 3372000,
    "deferredtaxassetinterestcarryforward": 554000,
    "deferredtaxassetspropertyplantandequipment": 215000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": 1977000,
    "deferredtaxassetstaxdeferredexpensereservesandaccruals": 1618000,
    "deferredtaxassetsgross": 69610000,
    "deferredtaxassetsvaluationallowance": 67457000,
    "deferredtaxassetsnet": 2153000,
    "deferredtaxliabilitiesgoodwillandintangibleassetsintangibleassets": 2153000,
    "deferredincometaxliabilities": 2153000,
    "unrecognizedtaxbenefits": 843000,
    "unrecognizedtaxbenefitsincreasesresultingfromcurrentperiodtaxpositions": 128000,
    "operatingleasesrentexpensenet": 1200000,
    "remainingestimatedobligation": 100000,
    "royaltyexpense": 700000,
    "percentageofrevenuesharepaymentrelatedtoacquireddiagnostictestrecognizedrevenuefornonscreeningtests": 0.08,
    "minimumannualvolumepercentagethereafter": 0.05,
    "periodofescalationsofsales": "through the first four years of sales",
    "losscontingencyaccrualatcarryingvalue": 210000,
    "operatingleasesfutureminimumpaymentsduecurrent": 775000,
    "operatingleasesfutureminimumpaymentsdueintwoyears": 149000,
    "operatingleasesfutureminimumpaymentsdueinthreeyears": 9000,
    "operatingleasesfutureminimumpaymentsdueinfouryears": 3000,
    "operatingleasesfutureminimumpaymentsdueinfiveyears": 1000,
    "operatingleasesfutureminimumpaymentsdue": 937000,
    "lessoroperatingleaseleasenotyetcommenceddescription": "The initial term of the Lease will extend twelve years (the Initial Term) from the commencement date, which is the earlier of: (i) the Company conducting revenue generating business (as defined in the Lease), or (ii) April 1, 2023 (the Commencement Date), unless earlier terminated in accordance with the Lease. The Company has two renewal options to extend the term of the Lease for an additional seven or ten year terms for each renewal."
  },
  {
    "date": "2020-12-30",
    "symbol": "BDSX",
    "period": "FY",
    "documenttype": "10-K",
    "amendmentflag": "false",
    "documentannualreport": "true",
    "documentperiodenddate": "December 31, 2020",
    "documentfiscalyearfocus": 2020,
    "documentfiscalperiodfocus": "FY",
    "entitycentralindexkey": 1439725,
    "currentfiscalyearenddate": "--12-31",
    "documenttransitionreport": "false",
    "entityfilenumber": "001-39659",
    "entityregistrantname": "Biodesix, Inc.",
    "entityincorporationstatecountrycode": "Delaware",
    "entitytaxidentificationnumber": "20-3986492",
    "entityaddressaddressline1": "2970 Wilderness Place",
    "entityaddressaddressline2": "Suite 100",
    "entityaddresscityortown": "Boulder",
    "entityaddressstateorprovince": "CO",
    "entityaddresspostalzipcode": 80301,
    "cityareacode": 303,
    "localphonenumber": "417-0500",
    "security12btitle": "Common Stock, par value $0.001 per share",
    "icfrauditorattestationflag": "false",
    "tradingsymbol": "BDSX",
    "securityexchangename": "The NASDAQ Global Market",
    "entitywellknownseasonedissuer": "No",
    "entityvoluntaryfilers": "Yes",
    "entitycurrentreportingstatus": "Yes",
    "entityinteractivedatacurrent": "Yes",
    "entityfilercategory": "Non-accelerated filer",
    "entitysmallbusiness": "true",
    "entityemerginggrowthcompany": "true",
    "entityextransitionperiod": "false",
    "entityshellcompany": "false",
    "entitypublicfloat": "null",
    "cashandcashequivalentsatcarryingvalue": 62126000,
    "accountsreceivablenetcurrent": 15304000,
    "otherassetscurrent": 8710000,
    "assetscurrent": 86140000,
    "propertyplantandequipmentnet": 3178000,
    "intangibleassetsnetexcludinggoodwill": 13260000,
    "otherassetsnoncurrent": 3461000,
    "goodwill": 15031000,
    "assetsnoncurrent": 34930000,
    "assets": 121070000,
    "accountspayablecurrent": 8964000,
    "accruedliabilitiescurrent": 7789000,
    "contractwithcustomerliabilitycurrent": 2800000,
    "notespayabletobankcurrent": 11840000,
    "putoptionliabilitycurrent": 3400000,
    "liabilitiescurrent": 32125000,
    "longtermnotespayable": 15926000,
    "businesscombinationcontingentconsiderationliabilitynoncurrent": 29932000,
    "otherliabilitiesnoncurrent": 1921000,
    "liabilitiesnoncurrent": 47779000,
    "liabilities": 79904000,
    "commonstockvalue": 27000,
    "additionalpaidincapital": 299953000,
    "retainedearningsaccumulateddeficit": -258814000,
    "stockholdersequity": -258814000,
    "liabilitiesandstockholdersequity": 121070000,
    "temporaryequityparorstatedvaluepershare": 0.001,
    "temporaryequitysharesoutstanding": 26562,
    "preferredstockparorstatedvaluepershare": 0.001,
    "preferredstocksharesauthorized": "null",
    "commonstockparorstatedvaluepershare": 0.001,
    "commonstocksharesauthorized": "null",
    "commonstocksharesissued": "null",
    "commonstocksharesoutstanding": "null",
    "revenues": 12600000,
    "directcostsandexpenses": 21998000,
    "researchanddevelopmentexpense": 900000,
    "sellinggeneralandadministrativeexpense": 34857000,
    "changeinfairvalueofcontingentconsiderationexcludingaccretionexpense": 818000,
    "operatingexpenses": 68491000,
    "operatingincomeloss": -22934000,
    "interestincomeother": 18000,
    "interestexpense": 7604000,
    "fairvalueadjustmentofwarrants": 1252000,
    "othernonoperatingincome": 422000,
    "othernonoperatingincomeexpense": -8416000,
    "netincomeloss": -31350000,
    "earningspersharebasicanddiluted": -6.48,
    "weightedaveragenumberofshareoutstandingbasicanddiluted": 4838000,
    "stockissuedduringperiodvaluestockoptionsexercised": 1340000,
    "stockissuedduringperiodsharesstockoptionsexercised": 368000,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 3709000,
    "stockissuedduringperiodvaluenewissues": 63757000,
    "stockissuedduringperiodsharesnewissues": 4000,
    "stockissuedduringperiodvalueconversionofconvertiblesecurities": 193959000,
    "stockissuedduringperiodsharesconversionofconvertiblesecurities": 20091,
    "adjustmentstoadditionalpaidincapitalequitycomponentofconvertibledebt": 26616000,
    "stockissuedduringperiodsharesconversionofconvertiblesecuritiescommonstock": 1848,
    "adjustmentstoadditionalpaidincapitalwarrantissued": 8274000,
    "capitalunitsdeductionsfromtotalcosttoinvestors": 5040000,
    "capitalunitstotalcosttoinvestors": 3203000,
    "profitloss": -31350000,
    "depreciationandamortization": 2903000,
    "amortizationofdebtdiscountpremium": 4389000,
    "sharebasedcompensation": 3709000,
    "businesscombinationcontingentconsiderationarrangementschangeinamountofcontingentconsiderationliability1": 818000,
    "accruedinterestonnotespayableandconvertiblenotespayable": 1226000,
    "amortizationoffinancingcosts": 144000,
    "provisionfordoubtfulaccounts": 296000,
    "gainlossondispositionofassets1": -48000,
    "increasedecreaseinaccountsreceivable": 10308000,
    "increasedecreaseinothercurrentassets": 6588000,
    "increasedecreaseinothernoncurrentassetsandliabilitiesnet": 1808000,
    "increasedecreaseinaccountspayableandaccruedliabilities": 11654000,
    "increasedecreaseincontractwithcustomerliability": 2249000,
    "netcashprovidedbyusedinoperatingactivities": -21366000,
    "paymentstoacquirepropertyplantandequipment": 1945000,
    "paymentsforproceedsfrompatentcostsandintangibleassetacquisitionnet": 232000,
    "paymentstoacquireoncimmune": 750000,
    "netcashprovidedbyusedininvestingactivities": -2927000,
    "proceedsfromissuanceinitialpublicoffering": 72000000,
    "proceedsfromstockoptionsexercised": 1340000,
    "proceedsfromconvertibledebt": 12955000,
    "proceedsfromnotespayable": 3085000,
    "paymentsofstockissuancecosts": 8243000,
    "proceedsfrompaymentsforotherfinancingactivities": -6000,
    "netcashprovidedbyusedinfinancingactivities": 81131000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": 56838000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalents": 62306000,
    "conversionofpreferredstockintocommonstock": 193959000,
    "conversionofstockamountconverted1": 26616000,
    "reclassificationofputoptionliabilitytoadditionalpaidincapital": 6650000,
    "valueofputoptionrecordedatissuanceofconvertiblenotespayable": 3389000,
    "interestpaidnet": 1844000,
    "reclassificationofwarrantliabilitytoadditionalpaidincapital": 1624000,
    "numberofcancertest": 4,
    "numberofcommercialbloodbasedtest": 2,
    "numberofsarscov2test": 2,
    "stockholdersequityreversestocksplit": "0.1684664-for-1",
    "classofwarrantorrightnumberofsecuritiescalledbywarrantsorrights": 103326,
    "errorcorrectionsandpriorperiodadjustmentsdescription": "The 2019 balance sheet has been updated to reflect an increase in goodwill and a reduction in accumulated deficit of $3.4 million related to the correction of an immaterial error recorded as part of the acquisition of Integrated Diagnostics, Inc. in 2018.",
    "numberofoperatingsegments": 1,
    "concentrationriskpercentage1": 0.76,
    "restrictedcash": 200000,
    "allowancefordoubtfulaccountsreceivable": 200000,
    "otherinventorysupplies": 3200000,
    "propertyplantandequipmentusefullife": "five years",
    "finitelivedintangibleassetusefullife": 10,
    "businessacquisitiondescriptionofacquiredentity": "If Indi elects to not exercise its option, the Company has 12 months to repurchase the common stock in two equal and consecutive quarterly cash installments totaling $37.0 million.",
    "paymentstoacquirebusinessesgross": 1200000,
    "longtermdebtfairvalue": 27766000,
    "liabilitiesfairvaluedisclosure": 29932000,
    "fairvaluemeasurementwithunobservableinputsreconciliationsrecurringbasisliabilityvalue": 29932000,
    "fairvaluemeasurementwithunobservableinputsreconciliationrecurringbasisliabilitypurchases": 3389000,
    "fairvaluemeasurementwithunobservableinputsreconciliationrecurringbasisliabilitygainlossincludedinearnings": -60000,
    "fairvaluemeasurementwithunobservableinputsreconciliationreclassifiedtoadditionalpaidincapital": -1624000,
    "percentageofprobabilitiesofcontingentconsiderationsuccessfulachievementmilestonediscountratesrange": 0.135,
    "classofwarrantorrightnumberofsecuritiescalledbyeachwarrantorright": 613333,
    "classofwarrantorrightexercisepriceofwarrantsorrights1": 4.46,
    "warrantsandrightsoutstandingmaturitydate": "February 23, 2028",
    "warrantsnotsettleableincashfairvaluedisclosure": 300000,
    "propertyplantandequipmentgross": 9902000,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 6724000,
    "depreciation": 839000,
    "finitelivedintangibleassetsgross": 16900000,
    "finitelivedintangibleassetsaccumulatedamortization": 4694000,
    "finitelivedintangibleassetsnet": 13186000,
    "indefinitelivedintangibleassetsexcludinggoodwillgross": 74000,
    "indefinitelivedintangibleassetsexcludinggoodwill": 74000,
    "intangibleassetsgrossexcludinggoodwill": 18448000,
    "intangibleassetsaccumulatedamortizationexcludinggoodwill": 5188000,
    "amortizationofintangibleassets": 2064000,
    "finitelivedintangibleassetsamortizationexpensenexttwelvemonths": 1946000,
    "finitelivedintangibleassetsamortizationexpenseyeartwo": 1940000,
    "finitelivedintangibleassetsamortizationexpenseyearthree": 1936000,
    "finitelivedintangibleassetsamortizationexpenseyearfour": 1928000,
    "finitelivedintangibleassetsamortizationexpenseyearfive": 1924000,
    "finitelivedintangibleassetsamortizationexpenseafteryearfive": 3512000,
    "employeerelatedliabilitiescurrent": 3975000,
    "accruedclinicaltrialexpensecurrent": 715000,
    "otheraccruedliabilitiescurrent": 3099000,
    "debtinstrumentcarryingamount": 3107000,
    "debtinstrumentunamortizeddiscountpremiumanddebtissuancecostsnet": 313000,
    "notespayable": 27766000,
    "notespayablecurrent": 11840000,
    "debtinstrumentinterestaddedtoprincipalvalue": 1700000,
    "debtinstrumentfrequencyofperiodicpayment": "Commencing March 2021 and continuing through the maturity date February 2023, the outstanding principal is repayable in 24 equal monthly installments.",
    "debtinstrumentdescription": "The PPP Loan matures on the two-year anniversary of the funding date, April 2022, and bears interest at a fixed rate of 1.00% per annum. Monthly principal and interest payments, less the amount of any potential forgiveness (as discussed below), will commence in September 2021. The Company did not provide any collateral or guarantees in connection with the PPP Loan, nor did the Company pay any facility charge to obtain the PPP Loan.",
    "longtermdebtmaturitiesrepaymentsofprincipalinnexttwelvemonths": 11840000,
    "longtermdebtmaturitiesrepaymentsofprincipalinyeartwo": 13919000,
    "longtermdebtmaturitiesrepaymentsofprincipalinyearthree": 2320000,
    "longtermdebt": 28079000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnonoptionequityinstrumentsoutstandingnumber": 79104,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnonoptionequityinstrumentsforfeitures": 925000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnonoptionequityinstrumentsperiodincreasedecrease": 613000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnonoptionsforfeituresandexpirationsinperiodweightedaverageexerciseprice": 5,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardnonoptionsreclassificationofwarrantliabilitytoadditionalpaidincapitalweightedaverageexerciseprice": -0.75,
    "classofwarrantorrighstdatefromwhichwarrantsorrightsexercisable": "2028-02-29",
    "commonstockvotingrights": "The holder of each share of common stock is entitled to one vote per share.",
    "advancedeposits": 3500000,
    "contractwithcustomerliabilityrevenuerecognized": 700000,
    "commonstockcapitalsharesreservedforfutureissuance": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardpercentageofoutstandingstockmaximum": 0.04,
    "sharebasedcompensationarrangementbysharebasedpaymentawardmaximumemployeesubscriptionrate": 0.15,
    "sharebasedcompensationarrangementbysharebasedpaymentawarddiscountfrommarketpriceofferingdate": 0.85,
    "descriptionofvotingpowerorvalueofstockforemployeeparticipationinofferingperiod": "No employee may participate in an offering period if the employee owns 5% or more of the total combined voting power or value of the Company’s stock.",
    "descriptionofofferingperiodunderplan": "The initial offering period will commence from January 1, 2021 through August 31, 2021.  On a going forward basis, the ESPP provides for successive six-month offering periods beginning on September 1st and March 1st of each year.",
    "sharebasedcompensationarrangementbysharebasedpaymentawardsharesissuedinperiod": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesauthorized": 831389,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesavailableforgrant": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardexpirationperiod": "ten years",
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingrights": "vest over three years, 40% over the first two years and the remaining 60% over the third year from the grant date.",
    "numberofequalannualinstallmentsforawardvesting": 3,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 828000,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 2.81,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestednumberofshares": 56155,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 2321000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": "eight years",
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingperiod1": "three years",
    "percentageoffullydilutedequityforbonusawarded": 0.01,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageexerciseprice": 11.11,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 42580000,
    "allocatedsharebasedcompensationexpense": 3709000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognized": 600000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": 3.7,
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingrightspercentage": 0.6,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiod": 52736,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestedweightedaveragegrantdatefairvalue": 6.83,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresandexpirationsinperiod": 55000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": 1190000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 1.82,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresandexpirationsinperiodweightedaverageexerciseprice": 0.6,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice": 3.65,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 2.35,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantedweightedaverageremainingcontractualterm1": "P0Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm1": "P6Y3M18D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableintrinsicvalue1": 21194000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.0034000000000000002,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P5Y8M23D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 0.77,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 2677000,
    "deferredtaxassetsoperatinglosscarryforwardssubjecttoexpiration": 233600000,
    "deferredtaxassetsresearchandexperimentationtaxcarryforwardssubjecttoexpiration": 3600000,
    "taxcreditcarryforwarddescription": "expire beginning in 2026",
    "valuationallowancedeferredtaxassetexplanationofchange": "Company does not believe it is more likely than not that it will realize the benefits of net deferred tax assets and, accordingly, has established a valuation allowance equal to 100% of net deferred tax assets.",
    "percentageofvaluationallowanceequaltonetdeferredtaxassets": 1,
    "valuationallowancedeferredtaxassetchangeinamount": 4900000,
    "incometaxexaminationdescription": "All years will remain open for examining by federal and state authorities for three and four years, respectively, from the date of utilization of any net operating loss carryforwards.",
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "effectiveincometaxratereconciliationstateandlocalincometaxes": 0.02,
    "effectiveincometaxratereconciliationtaxcreditsresearch": -0.01,
    "effectiveincometaxratereconciliationpermanentitems": 0.06,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": -0.16,
    "deferredtaxassetsoperatinglosscarryforwards": 53128000,
    "deferredtaxassetstaxcreditcarryforwardsresearch": 2860000,
    "deferredtaxassetspropertyplantandequipment": 279000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": 865000,
    "deferredtaxassetstaxdeferredexpensereservesandaccruals": 1406000,
    "deferredtaxassetsgross": 58538000,
    "deferredtaxassetsvaluationallowance": 56083000,
    "deferredtaxassetsnet": 2455000,
    "deferredtaxliabilitiesgoodwillandintangibleassetsintangibleassets": 2455000,
    "deferredincometaxliabilities": 2455000,
    "unrecognizedtaxbenefits": 715000,
    "unrecognizedtaxbenefitsincreasesresultingfromcurrentperiodtaxpositions": 106000,
    "unrecognizedtaxbenefitsincreasesresultingfrompriorperiodtaxpositions": 609000,
    "operatingleasesrentexpensenet": 1700000,
    "royaltyexpense": 100000,
    "percentageofrevenuesharepaymentrelatedtoacquireddiagnostictestrecognizedrevenuefornonscreeningtests": 0.08,
    "minimumannualvolumepercentagethereafter": 0.05,
    "periodofescalationsofsales": "through the first four years of sales",
    "revenueshareexpenses": 300000,
    "operatingleasesfutureminimumpaymentsduecurrent": 703000,
    "operatingleasesfutureminimumpaymentsdueintwoyears": 724000,
    "operatingleasesfutureminimumpaymentsdueinthreeyears": 112000,
    "operatingleasesfutureminimumpaymentsdue": 1539000,
    "definedcontributionplanplannameextensiblelist": "bdsx:FourZeroOneKPlanMember"
  }
]